ELOX logo

Eloxx Pharmaceuticals (ELOX) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

26 April 1999

Indexes:

Not included

Description:

Eloxx Pharmaceuticals focuses on developing innovative treatments for genetic diseases caused by nonsense mutations. Their main goal is to improve the lives of patients with rare conditions by using advanced therapies that target the underlying genetic issues, aiming for effective and safe solutions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 25, 2024

Recent annual earnings:

Apr 03, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 02, 2022

Analyst ratings

Recent major analysts updates

11 July '23 Oppenheimer
Outperform
06 Apr '23 Oppenheimer
Outperform
23 May '22 Piper Sandler
Overweight
09 May '22 HC Wainwright & Co.
Neutral
17 Dec '21 Oppenheimer
Outperform
18 Nov '21 HC Wainwright & Co.
Neutral
11 Nov '21 HC Wainwright & Co.
Neutral
30 June '21 Mizuho
Buy
27 May '21 B. Riley Securities
Buy
11 June '20 Citigroup
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
ELOX
globenewswire.com11 July 2024

First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations

Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
ELOX
InvestorPlace05 December 2023

While getting kicked off an exchange typically signals about the biggest warning sign you can possibly receive, a (somewhat) rational argument exists for delisted stocks to buy. Psychologically, companies go through much anxiety doing whatever they can to stay listed in a major exchange.

This Small Cap Stock Surged Over 100%
This Small Cap Stock Surged Over 100%
This Small Cap Stock Surged Over 100%
ELOX
MarketBeat12 July 2023

Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals NASDAQ: ELOX rocketed almost 100% yesterday after receiving an increased price target from Oppenheimer.

Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
ELOX
InvestorPlace16 May 2023

Eloxx Pharmaceuticals (NASDAQ: ELOX ) stock is falling hard on Tuesday after the company provided a weak earnings report for Q1 2023. The bad news for ELOX stock starts with its losses per share of $2.88 cents.

Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
ELOX
Zacks Investment Research15 May 2023

Senesco Technologies Inc. (ELOX) came out with a quarterly loss of $2.88 per share versus the Zacks Consensus Estimate of a loss of $2.55. This compares to loss of $5.20 per share a year ago.

FAQ

  • What is the primary business of Eloxx Pharmaceuticals?
  • What is the ticker symbol for Eloxx Pharmaceuticals?
  • Does Eloxx Pharmaceuticals pay dividends?
  • What sector is Eloxx Pharmaceuticals in?
  • What industry is Eloxx Pharmaceuticals in?
  • What country is Eloxx Pharmaceuticals based in?
  • When did Eloxx Pharmaceuticals go public?
  • Is Eloxx Pharmaceuticals in the S&P 500?
  • Is Eloxx Pharmaceuticals in the NASDAQ 100?
  • Is Eloxx Pharmaceuticals in the Dow Jones?
  • When was Eloxx Pharmaceuticals's last earnings report?
  • When does Eloxx Pharmaceuticals report earnings?
  • Should I buy Eloxx Pharmaceuticals stock now?

What is the primary business of Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals focuses on developing innovative treatments for genetic diseases caused by nonsense mutations. Their main goal is to improve the lives of patients with rare conditions by using advanced therapies that target the underlying genetic issues, aiming for effective and safe solutions.

What is the ticker symbol for Eloxx Pharmaceuticals?

The ticker symbol for Eloxx Pharmaceuticals is NASDAQ:ELOX

Does Eloxx Pharmaceuticals pay dividends?

No, Eloxx Pharmaceuticals does not pay dividends

What sector is Eloxx Pharmaceuticals in?

Eloxx Pharmaceuticals is in the Healthcare sector

What industry is Eloxx Pharmaceuticals in?

Eloxx Pharmaceuticals is in the Biotechnology industry

What country is Eloxx Pharmaceuticals based in?

Eloxx Pharmaceuticals is headquartered in United States

When did Eloxx Pharmaceuticals go public?

Eloxx Pharmaceuticals's initial public offering (IPO) was on 26 April 1999

Is Eloxx Pharmaceuticals in the S&P 500?

No, Eloxx Pharmaceuticals is not included in the S&P 500 index

Is Eloxx Pharmaceuticals in the NASDAQ 100?

No, Eloxx Pharmaceuticals is not included in the NASDAQ 100 index

Is Eloxx Pharmaceuticals in the Dow Jones?

No, Eloxx Pharmaceuticals is not included in the Dow Jones index

When was Eloxx Pharmaceuticals's last earnings report?

Eloxx Pharmaceuticals's most recent earnings report was on 25 November 2024

When does Eloxx Pharmaceuticals report earnings?

The date for Eloxx Pharmaceuticals's next earnings report has not been announced yet

Should I buy Eloxx Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions